Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens

Critical Care Medicine

Volumn 26, Issue 5, 1998, Pages 947-956

  Shafer, Audrey ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complications; Critical care; Infusion; Intensive care; Intravenous; Lorazepam; Mechanical ventilation; Midazolam; Propofol; Sedation; Tolerance; Withdrawal

Indexed keywords

ALFENTANIL; CORTICOTROPIN; FENTANYL; HYDROCORTISONE; KETAMINE; LORAZEPAM; MIDAZOLAM; MORPHINE; OPIATE; PROPOFOL;

ACUTE PSYCHOSIS; CONTINUOUS INFUSION; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; HYPOTENSION; HYPOVOLEMIA; INTENSIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SEDATION; TACHYPHYLAXIS;

CONSCIOUS SEDATION; CRITICAL CARE; ECONOMICS, PHARMACEUTICAL; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MIDAZOLAM;

EID: 0031898657     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199805000-00034     Document Type: Review

References (113)

1. Barr J, Donner A: Optimal dosing strategies for sedatives and analgesics in the intensive care unit. Crit Care Clin 1995; 11:827-847
2. Buck ML, Blumer JL: Opioids and other analgesics. Crit Care Clin 1991; 7:615-637
3. Lehmkuhl P, Pichlmayr I: Intensive care sedation with propofol or midazolam infusions. J Drug Dev 1991; 4: 72-73
4. Burns AM, Shelly MP, Park GR: The use of sedative agents in critically ill patients. Drugs 1992; 43:507-515
5. Mendel PR, White PF: Sedation of the critically ill patient. Int Anesthesiol Clin 1993; 31:185-200
6. Merriman HM: The techniques used to sedate ventilated patients. Intensive Care Med 1981; 7:217-224
7. Bion JF, Ledingham IM: Sedation in the intensive care - A postal survey. Correspondence. Intensive Care Med 1987; 13:215-216
8. Shapiro BA, Warren J, Egol AB et al: Practice parameters for intravenous analgesia and sedation for adult patients in the intensive care unit: An executive summary. Crit Care Med 1995; 23:1596-1600
9. Watt I, Ledingham IM: Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39:973-981
10. Snellen F, Lauwers P, Demeyere R, et al: The use of midazolam versus propofol for short-term sedation following coronary artery bypass grafting. Intensive Care Med 1990; 16: 312-316
11. Menza MA, Murray GB, Holmes VF, et al: Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: Intravenous haloperidol versus intravenous haloperidol plus benzodiazepines. Heart Lung 1988; 17;238-241
12. Sinclair ME, Suter PM: Detection of overdosage of sedation in a patient with renal failure by absence of lower oesophageal motility. Intensive Care Med 1988; 14:69-71
13. Ramsay MAE, Savege TM, Simpson BJR, et al: Controlled sedation with alphaxalone-alphadolone. BMJ 1974; 2:656-659
14. Avramov MN, White PF: Methods for monitoring the level of sedation. Crit Care Clin 1995; 11:803-826
15. Hansen-Flaschen J, Cowen J, Polomano RC: Beyond the Ramsey scale: Need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med 1994; 22: 732-733
16. Wansbrough SR, White PF: Sedation scales: Measures of calmness or somnolence? Anesth Analg 1993; 76: 219-221
17. Costa J, Cabré L, Molina R, et al: Cost of ICU sedation: Comparison of empirical and controlled sedation methods. Clin Intensive Care 1994; 5: 17-21
18. Macnab AJ, Levine M, Glick N, et al: A research tool for measurement of recovery from sedation: The Vancouver sedative recovery scale. J Ped Surg 1991; 26:1263-1267
19. Macnab AJ, Levine M, Glick N, et al: The Vancouver sedative recovery scale for children: Validation and reliability of scoring based on videotaped instruction. Can J Anaesth 1994; 41: 913-918
20. Laing ASM: The applicability of a new sedation scale for intensive care. Intensive and Critical Care Nursing 1992; 8:149-152
21. Chernik DA, Tucker M, Gigli B, et al: Validity and reliability of the neuro-behavioral assessment scale. J Clin Psychopharm 1992; 12:43-48
22. Marx CM, Smith PG, Lowrie LH, et al: Optimal sedation of mechanically ventilated pediatric critical care patients. Crit Care Med 1994; 22:163-170
23. Wang DY: Assessment of sedation in the ICU. Intensive Care World 1993; 10:193-196
24. Haberthur C, Lehmann F, Ritz R: Assessment of depth of midazolam sedation using objective parameters. Intensive Care Med 1996; 22:1385-1390
25. Jacobs JR, Reves JG, Glass PSA: Rationale and technique for continuous infusions in anesthesia. Int Anesthesiol Clin 1991; 29:23-38
26. Reves JG, Fragen RJ, Vinik, R, et al: Midazolam: Pharmacology and uses. Anesthesiology 1985; 62:310-324
27. Geller E, Halpern P, Barzelai E, et al: Midazolam infusion and the benzodiazepine antagonist flumazenil for sedation of intensive care patients. Resuscitation 1988; 16(Suppl):S31-S39
28. Barvais L, Dejonckheere M, Dernovoi B, et al: Continuous infusion of midazolam or bolus of diazepam for postoperative sedation in cardiac surgical patients. Acta Anaesthesiol Belg 1988; 39:239-245
29. White PF: Clinical uses of intravenous anesthetic and analgesic infusions. Anesth Analg 1989; 68:161-171
30. Shafer SL: Towards optimal intravenous dosing strategies. Semin Anesth 1993; 12:222-234
31. Stokes DN, Hutton P: Rate-dependent induction phenomena with propofol: Implications for the relative potency of intravenous anesthetics. Anesth Analg 1991; 72:578-583
32. White PF: Use of continuous infusion versus intermittent bolus administration of fentanyl or ketamine during outpatient anesthesia. Anesthesiology 1983; 59:294-300
33. White PF, Coe V, Shafer A, Sung M-L: Comparison of alfentanil with fentanyl as adjuvants during outpatient surgery. Anesthesiology 1986; 64:99-106
34. Pathak KS, Brown RH, Nash CL Jr, et al: Continuous opioid infusion for scoliosis surgery. Anesth Analg 1983; 62:841-845
35. Miller DR, Martineau RJ, Hull KA, et al: Optimizing sedation following major vascular surgery: A double-blind study of midazolam administered by continuous infusion. Can J Anaesth 1994; 41:782-793
36. Westphal LM, Cheng EY, White PF, et al: Use of midazolam infusion for sedation following cardiac surgery. Anesthesiology 1987; 67:257-262
37. Sladen RN: Report on infusion in the surgical ICU. In: Midazolam Infusion for Anesthesia and Intensive Care. Vinik HR (Ed). Princeton, NY, Excerpta Medica, 1989, pp 51-57
38. Du Gres B, Flamens C: A comparison of propofol and midazolam infusion for postoperative sedation after cardiac surgery. Abstr. J Cardiothoracic Anesth 1990; 4(Suppl 3):101
39. Geller E, Weinbroum A, Sorkine P, et al: Midazolam versus propofol for prolonged sedation in the ICU: A randomized, controlled prospective comparison. Abstr. Anesthesiology 1991; 75:A269
40. Buchalter SE: Midazolam sedation in a medical intensive care unit: Three case histories. In: Anesthesia and Sedation by Continuous Infusion. Symposium, May 31-June 1, 1991. Reves JG, Sladen RN (Eds). Princeton, NY, Excerpta Medica, 1992, pp 77-81
41. Higgins TL, Yared JP, Estafanous FG, et al: Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting. Crit Care Med 1994; 22:1415-23
42. Chaudhri S, Kenny GNC: Sedation after cardiac bypass surgery: comparison of propofol and midazolam in the presence of a computerized closed loop arterial pressure controller. Br J Anaesth 1992; 68:98-99
43. Roekaerts PMHJ, Huygen FJPM, et al: Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery. J Cardiothoracic Vasc Anesth 1993; 7:142-147
44. Adams HA: Analgesia and sedation on patients with sepsis syndrome. Anaesthesist 1995; 44(Suppl 3):S573-S579
45. Pappagallo S, Giannoni S, Romagnoli P, et al: Propofol-midazolam in continuous infusion for sedation in intensive care. Minerva Anestesiol 1992; 59:441-446
46. Gross JB, Blouin RT, Zandsberg S, et al: Effect of flumazenil on ventilatory drive during sedation with midazolam and alfentanil. Anesthesiology 1996; 85:713-720
47. Blouin RT, Conard PF, Perreault S, et al: The effect of flumazenil on midazolam-induced depression of the ventilatory response to hypoxia during isohypercarbia. Anesthesiology 1993; 78:635-641
48. Gross JB, Weller RS, Conard P: Flumazenil antagonism of midazolam-induced ventilatory depression. Anesthesiology 1991; 75:179-185
49. Bertaccini E, Geller E: Benzodiazepine antagonists and their role in anaesthesia and critical care. Anaesth Pharm Rev 1995; 3:74-81
50. Byatt CM, Lewis LD, Dawling S, et al: Accumulation of midazolam after repeated dosage in patients receiving mechanical ventilation in an intensive care unit. BMJ 1984; 289:799-800
51. Klotz U, Arvela P, Rosenkranz B: Effect of single doses of cimetidine and ranitidine on the steady state plasma levels of midazolam. Clin Pharmacol Ther 1985; 38:652-655
52. Shelly MP, Mendel L, Park GR: Failure of critically ill patients to metabolise midazolam. Anaesthesia 1987; 42:619-626
53. Shafer A, Doze VA, White PF: Pharmacokinetic variability of midazolam infusions in critically ill patients. Crit Care Med 1990; 18:1039-1041
54. Malacrida R, Fritz ME, Suter PM, et al: Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992; 20: 1123-1126
55. Park GR, Miller E, Navapurkar V: What changes drug metabolism in critically ill patients? - II. Serum inhibits the metabolism of midazolam in human microsomes. Anaesthesia 1996; 51:11-15
56. Gill AM, Leach HJ, Barker C, et al: Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr 1995; 84:438-441
57. Bauer TM, Ritz R, Haberthur C, et al: Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet 1995; 346:145-147
58. Bodenham A, Brownlie G, Dixon JB, et al: Reversal of sedation by prolonged infusion of flumazenil (Anexate, RO 15-1788). Anaesthesia 1988; 43: 376-378
59. Ortiz JC, Castillo J, Alcón, et al: Profound and prolonged neurologic depression following intravenous midazolam perfusion. Rev Esp Anest y Reanim 1992; 39:324
60. Gyasi HK, Fahr J, Kurian E, et al: Midazolam for prolonged intravenous sedation in patients with tetanus. Middle East J Anesthesiology 1993; 12:135-141
61. Fiset P, Lemmens HL, Egan TE, et al: Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin Pharm Ther 1995; 58:567-582
62. Bion JF, Chow B, Bowden MI: Aims and methods of assessment of sedation in intensive care. J Drug Dev 1991; 4(Suppl 3):19-25
63. Fisher GC, Clapham MCC, Hutton P: Flumazenil in intensive care - The duration of arousal after an assessment dose. Anaesthesia 1991; 46:413-416
64. Park GR, Navapurkar VU, Ferenci P: The role of flumazenil in the critically ill. Acta Anaesthesiol Scand 1995; 108(Suppl):23-34
65. Pepperman ML: Double-blind study of the reversal of midazolam-induced sedation in the intensive care unit with flumazenil: Effect on weaning from ventilation. Anaesth Intensive Care 1990; 18:38-44
66. Breheny FX: Reversal of midazolam sedation with flumazenil. Crit Care Med 1992; 20:736-739
67. Spivey WH: Flumazenil and seizures: Analysis of 43 cases. Clin Ther 1992; 14:292-305
68. Ledingham IM, Bion JF, Newman LH, et al: Mortality and morbidity amongst sedated intensive care patients. Resuscitation 1988; 16(Suppl):S69-S77
69. Hughes J, Gill A, Leach HJ, et al: A prospective study of the adverse effects of midazolam on withdrawal in critically ill children. Acta Paediatr 1994; 83:1194-1199
70. Riker RR, Fraser GL, Cox PM: Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994; 22:433-440
71. Rowland M, Tozer TN (Eds): Clinical Pharmacokinetics: Concepts and Applications. Third Edition. Media, PA, Williams & Wilkins, 1995, p 62
72. Bronson ME: Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil. Pharmacol Biochem Behav 1995; 51:481-490
73. Ramsey-Williams VA, Wu Y, Rosenberg HC: Comparison of anti-convulsant tolerance, crosstolerance, and benzodiazepine receptor binding following chronic treatment with diazepam or midazolam. Pharmacol Biochem Behav 1994; 48:765-772
74. Sannerud CA, Marley RJ, Serdikoff SL, et al: Tolerance to the behavioral effects of chlordiazepoxide: Pharmacological and biochemical selectivity. J Pharmacol Exp Ther 1993; 267: 1311-1320
75. Shelly MP, Sultan MA, Bodenham A, et al: Midazolam infusions in critically ill patients. Eur J Anaesthesiol 1991; 8:21-27
76. Tobias JD, Deshpande JK, Pietsch JB, et al: Pentobarbital sedation for patients in the pediatric intensive care unit. South Med J 1995; 88:290-294
77. Tanigami H, Yahagi N, Kumon K, et al: Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs 1997; 21:21-23
78. Hantson Ph, Clemessy JL, Baud FJ: Withdrawal syndrome following midazolam sedation. Intensive Care Med 1995; 21:190-194
79. Littler C, Scubie SD, Shelly MP: Withdrawal of sedation after long-term ventilation on the ICU. Clin Intensive Care 1995; 6:83-85
80. Mets B, Horsell A, Linton M: Midazolam-induced benzodiazepine withdrawal syndrome. Anesthesia 1991; 46:28-29
81. Busto U, Sellers EM, Naranjo CA, et al: Withdrawal reaction after long-term therapeutic use of benzodiazepines. N Engl J Med 1986; 315: 854-859
82. Ducharme MP, Munzenberger P: Severe withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion. Pharmacotherapy 1995; 15:665-668
83. van Engelen BG, Gimbrere JS, Booy LH: Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Ann Pharmacother 1993; 27:579-581
84. Tobias JD, Deshpande JK, Gregory DF: Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Med 1994; 20:504-507
85. Vinik HR, Bradley EL, Kissin I: Triple anesthetic combination: Propofol-midazolam-alfentanil. Anesth Analg 1994; 78:354-358
86. Vinik HR, Bradley EL, Kissin I: Midazolam-alfentanil synergism for anesthetic induction in patients. Anesth Analg 1989; 69:213-217
87. Kissin I, Vinik HR, Castillo R, et al: Alfentanil potentiates midazolam-induced unconsciousness in sub-analgesic doses. Anesth Analg 1990; 71:65-69
88. Tverskoy M, Fleyshman G, Ezry J, et al: Midazolam-morphine sedative interaction in patients. Anesth Analg 1989; 68:282-285
89. Sheridan RL, McEttrick M, Bacha G, et al: Midazolam infusion in pediatric patients with burns who are undergoing mechanical ventilation. J Burn Care Rehab 1994; 15:515-518
90. Heikkila H, Jalonen J, Arola M, et al: Midazolam as adjunct to high-dose fentanyl anaesthesia for coronary artery bypass grafting operation. Acta Anaesth Scand 1984; 28:683-689
91. Newman M, Reves JG: Pro: Midazolam is the sedative of choice to supplement narcotic anesthesia. J Cardiothorac Vasc Anesth 1993;7: 615-619
92. Rattan AK, Sribanditmongkol P: Effect of morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat. Pharmacol Biochem Behav 1994; 48:357-361
93. McDonald CF, Thomson SA, Scott NC, et al: Benzodiazepine-opiate antagonism - A problem in intensive-care therapy. Intensive Care Med 1986; 12:39-42
94. Luger TJ, Hill HF, Schlager A: Can midazolam diminish sufentanil analgesia in patients with major trauma? A retrospective study with 43 patients. Drug Metabol Drug Interact 1992; 10:177-184
95. Hansen-Flaschen JH, Brazinsky S, Basile C, et al: Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure. JAMA 1991; 266:2870-2875
96. Armstrong DK, Crisp CB: Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care. New Horiz 1994; 2: 85-93
97. Heikkila H, Jalonen J, Laaksonen V et al: Lorazepam and high-dose fentanyl anaesthesia: Effects on haemodynamics and oxygen transportation in patients undergoing coronary revascularization. Acta Anaesth Scand 1984; 28:357-361
98. Laine GA, Hossain SM, Solis RT, et al: Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 1995; 29:1110-1114
99. Cernaianu AC, DelRossi AJ, Flum DR, et al: Lorazepam and midazolam in the intensive care unit: A randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med 1996; 24:222-228
100. Pohlman AS, Simpson KP, Hall JB: Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: A prospective, randomized study. Crit Care Med 1994; 22:1241-1247
101. Beyer R, Seyde WC: Propofol versus midazolam. Long-term sedation in the intensive care unit: A comparison of propofol with midazolam. Anaesthetist 1992; 41:335-341
102. Boeke A, Lauwers J, Schurink G: A pilot study to compare the use of propofol and midazolam for long-term sedation. J Drug Dev 1989; 2:71-72
103. Kox W, Brydon C: Effect of sedation with alfentanil, midazolam or propofol on oxygen transport variables in the critically ill. Abstr. Br J Anaesth 1990; 65:278P
104. Wahr JA, Plunkett JJ, Ramsay JG, et al: Cardiovascular responses during sedation after coronary revascularization. Incidence of myocardial ischemia and hemodynamic episodes with propofol versus midazolam. Anesthesiology 1996; 84:1350-1360
105. Aitkenhead AR, Pepperman ML, Willatts SM, et al: Comparison of propofol and midazolam for sedation in critically ill patients. Lancet 1989; 8665:704-708
106. Chamorro C, de Latorre FJ, Montero A, et al: Comparative study of propofol versus midazolam in the sedation of critically ill patients: Results of a prospective, randomized, multicenter trial. Crit Care Med 1996;24: 932-939
107. Fulton B, Sorkin EM: Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50:636-657
108. Boyd O, Mackay CJ, Rushmer F, et al: Propofol or midazolam for short-term alterations in sedation. Can J Anaesth 1993; 40:1142-1147
109. Ronan KP, Gallagher TJ, George B, et al: Comparison of propofol and midazolam for sedation in intensive care unit patients. Crit Care Med 1995; 23:286-293
110. O'Donnell NG, McSharry CP, Wilkinson PC, et al: Comparison of the inhibitory effect of propofol, thiopentone and midazolam on neutrophil polarization in vitro in the presence or absence of human serum albumin. Br J Anaesth 1992; 69:70-74
111. Carrasco G, Molina R, Costa J et al: Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients: A cost-benefit analysis. Chest 1993; 103:557-564
112. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C, et al: Prolonged sedation of critically ill patients with midazolam or propofol: Impact on weaning and costs. Crit Care Med 1997; 25:33-40
113. Hadbavny AM, Hoyt JW: Promotion of cost-effective benzodiazepine sedation. Am J Hosp Pharm 1993; 50: 660-661